Transanal Total Mesorectal Excision for Rectal Cancer

Sue J Hahn; Ameer Farooq; Patricia Sylla

doi:10.1016/j.yasu.2023.04.002

Transanal Total Mesorectal Excision for Rectal Cancer

Adv Surg. 2023 Sep;57(1):187-208. doi: 10.1016/j.yasu.2023.04.002. Epub 2023 May 17.

Authors

Sue J Hahn¹, Ameer Farooq², Patricia Sylla³

Affiliations

¹ Division of Colon and Rectal Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, Box 1259, New York, NY 10029, USA.
² Division of Colorectal Surgery, Department of Surgery, Queen's University, Kingston General Hospital, 76 Stuart Street, Kingston, ON K7L 2V7, USA.
³ Division of Colon and Rectal Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, 5 East 98th Street, Box 1259, New York, NY 10029, USA. Electronic address: [email protected].

PMID: 37536853
DOI: 10.1016/j.yasu.2023.04.002

Abstract

Transanal total mesorectal excision (taTME) is a technique where rectal dissection is begun transanally in a "bottom-up" fashion. This technique facilitates dissection of the most distal part of the rectum and allows the establishment of the distal margin for rectal cancer. TaTME has proven its utility in facilitating low rectal dissection with significantly lower conversion rates and acceptable perioperative, oncological, and functional outcomes. However, taTME remains a challenging technique to learn and adopt. This article describes the technique, indications, and outcomes of taTME in rectal cancer during the last decade.

Keywords: Innovation; Minimally invasive surgery; Rectal cancer; Total mesorectal excision (TME); Transanal total mesorectal excision (taTME).

Publication types

Review

MeSH terms

Humans
Laparoscopy* / methods
Postoperative Complications / surgery
Proctectomy* / methods
Rectal Neoplasms* / surgery
Rectum / surgery
Transanal Endoscopic Surgery* / methods
Treatment Outcome